1000 resultados para Su-25
Resumo:
Boletín semanal para profesionales sanitarios de la Secretaría General de Calidad, Innovación y Salud Pública de la Consejería de Igualdad, Salud y Políticas Sociales
Resumo:
La constant evolució del món empresarial al llarg de les últimes décades, ha canviat, segueix evolucionant i continuará transformant l’ambient laboral així com les interaccions dins l’empresa en quant a la relació empresari-empleat es refereix. Aquest treball pretén presentar l’esmentada evolució així com pusar de relieve el cada cop més rellevant Factor Humà, que es perfila com l’eina idònia del directiu del futur, una eina que dibuixarà un nou model de gestió basat en les competències.
Resumo:
The impact on health of alcohol in a given society is mainly related with the volume and pattern of drinking, and these are related with individual factors, but also with environmental factors, among which public policies are important determinants. Public policies may favour or reduce alcohol use, and thus have a substantial preventive capacity. The effectiveness of policies to prevent the harm caused by alcohol has been reviewed in recent documents, which provide evidence to extract recommendations. This paper reviews the most effective policies to reduce the harm caused by alcohol, with an emphasis in the use of taxes to increase its cost, availability regulation, and policies on drinking and driving. The regulation of alcohol promotion and publicity is also assessed, as well as the detection and treatment of alcohol abuse and dependence. The state of alcohol related policies in Spain is analysed, as well as the obstacles, for the adoption of policies more prone to prevention, and recommendations for the future are made.
Resumo:
BACKGROUND: There is a prevalence of diabetes mellitus (DM), unknown DM and stress hyperglycemia among hospital patients, and the nutritional treatment is a key part of care, where carbohydrates (CH) intake is a controversial issue. There is also a discussion on the increase of prevalence for DM, obesity and metabolic disease with refined CH or sugar. OBJECTIVES: This review examines the recommendations from different scientific societies about the percentage of CH in the total calorie intake of the diabetic patient, the CH value in the glycemic index and glycemic load, the new CH included in enteral formulae and the association of refined CH with the high prevalence of DM and metabolic disease. METHODS: Systematic review of literature using the electronic scientific databases Pubmed, Science Direct, Scielo, Scopus and Medline. CONCLUSIONS: Scientific societies are flexible about the CH intake in the diet of diabetic patients, suggesting to customize it according to each metabolic profile. Using the glycemic index and glycemic load can provide an extra benefit in the postprandial glycemic control. The new diabetes-specific enteral formulae, with fructooligosaccharides, resistant maltodextrins and fructose-free show efficacy in improving the glycemic control, although more controlled and long-term studies are needed. There is still some controversy about the links between sugar intake and DM, obesity and metabolic disease, although this relationship would be more linked to an increase of the total calorie intake than to a specific nutrient. .
Resumo:
En aquest treball, prenent com a marc teòric de referència la deconstrucció de la dicotomia públic/privat realitzada per la teoría feminista en aquestes últimes dècades, i les anàlisis jurídicfeministes del dret, posem de manifest com el Dret de la Unió Europea sobre la conciliació de la vida familiar i laboral està articulat acord amb aquesta dicotomia, i en conseqüència, no té en compte els interessos de les dones en tot el seu abast, ja que potencia la seva participació en el treball remunerat però sense resoldre el problema de les desigualtats entre homes i dones en relació amb les càrregues familiars i domèstiques.
Resumo:
Benzodiazepines and hypnotic Z-drugs are indicated for the short-term treatment of insomnia and anxiety (4 weeks maximum) at the lowest dose possible. Despite the recommendations for short-term use and its unfavourable effects, the level of consumption of benzodiazepines in our context is high and it is continually rising. Prolonged medication usage is associated with adverse effects and significant risks, particularly in the elderly, and should, therefore, be avoided when approaching new treatment. If a previous treatment assessed is found to be inappropriate, its possible withdrawal must be considered. Benzodiazepines withdrawal is based on a gradual dose reduction and should be managed by establishing a doctor-patient relationship of trust to encourage and accomplish discontinuation.
Resumo:
INTRODUCTION: Morbid obesity has grown enormously in recent decades, representing a serious public health problem. It is characterized by the accumulation of body fat and the presence of diseases associated with it, which affects the physical, psychological and social level. It has been considered bariatric ciguría as the most effective treatment for weight loss, getting the welfare of the obese person in the above-described drawings. OBJECTIVE: To evaluate the impact on the quality of life of obese people before and after bariatric surgery be tapped using the technique of laparoscopic gastrectomy (GVL) in a follow short, medium and long term. METHOD: The study population are all people with morbid obesity and are candidates for surgery, presenting at Torrecárdenas Bariatric Surgery Hospital (Almería). The design is a descriptive, longitudinal study, prospective. RESULTS: After evaluation of the obese patients a year, two years and five years after surgery, there has been decrease in weight, therefore decrease in BMI and the degree of obesity, improvement or disappearance of comorbidities and increased CV variables. DISCUSSION: The GVL gets reduce excess weight and therefore BMI and the degree of obesity, as well as the number of obesity-associated diseases, thus increasing the CV.
Resumo:
Con la Europa del 2004 acercándose rápidamente, esta obra no pretende re-explorar el proceso de ampliación una vez más. Este trabajo pretende aportar una perspectiva aproximativa de aquello que le espera a la Unión Europea tras su ampliación. El acento se pone en las distintas oportunidades y desafíos que la acción exterior de la Unión tendrá que afrontar en su futuro ampliado, centrándose especialmente en la UE-25 como una actor en política exterior a la vez que un proveedor de seguridad. El objetivo de los capítulos de la primera parte de este volumen es reflejar cómo se producirá la adaptación de los nuevos miembros a las cuatro áreas de impacto exterior de la UE (PESC, PESD, minorías y asilo), y consecuentemente, de qué modo influirán éstos nuevos actores. En la última parte de la obra, se explora la naturaleza de las nuevas fronteras de la UE-25.
Resumo:
El conflicto de Oriente Próximo escribió una más de sus tantas páginas el pasado verano. A principios de julio, las milicias de Hezbollah secuestraron a dos soldados israelíes cerca de la frontera del Líbano y se lanzaron cohetes Katiuska hacia el norte de Israel. Este suceso provocó la respuesta armada israelí y el inicio de un largo verano de bombardeos en el sur del Líbano, en los suburbios de Beirut y en el norte de Israel. La escalada bélica se llevó a cabo delante de una comunidad internacional incapaz de responder con contundencia a la desproporcionada respuesta israelí y a los continuos ataques de Hezbollah en el norte de Israel. Por su lado, la Unión Europea evidenció la divergencia de pareceres entre sus 25 estados miembros. Así, mientras que países como Francia, España o Italia criticaban la desproporción de la actuación israelí; Reino Unido o Alemania reconocían a Israel el derecho a la legítima defensa.
Resumo:
Enfrentar la muerte como final inevitable de todo ser humano es una cuestión que ha preocupado a la humanidad desde sus orígenes y ha motivado innumerable literatura en todos los tiempos. Quizás por esta razón, la actuación del profesional sanitario en el tramo final de la vida de sus pacientes se ha enmarcado tradicionalmente en la toma de decisiones individuales o bien de forma conjunta con la familia del enfermo, debatiéndose entre su máxima aspiración de salvar esa vida y la aceptación del desenlace inevitable como consecuencia de la enfermedad. Poco a poco se va interiorizando la obligación ética y deontológica de saber ver el momento en el que hay que decir basta y limitarse a acompañar al paciente en su proceso de muerte, haciéndolo lo más indoloro y apacible que se pueda.
Resumo:
BACKGROUND: Fractures in men are a major health issue, and data on the antifracture efficacy of therapies for osteoporosis in men are limited. We studied the effect of zoledronic acid on fracture risk among men with osteoporosis. METHODS: In this multicenter, double-blind, placebo-controlled trial, we randomly assigned 1199 men with primary or hypogonadism-associated osteoporosis who were 50 to 85 years of age to receive an intravenous infusion of zoledronic acid (5 mg) or placebo at baseline and at 12 months. Participants received daily calcium and vitamin D supplementation. The primary end point was the proportion of participants with one or more new morphometric vertebral fractures over a period of 24 months. RESULTS: The rate of any new morphometric vertebral fracture was 1.6% in the zoledronic acid group and 4.9% in the placebo group over the 24-month period, representing a 67% risk reduction with zoledronic acid (relative risk, 0.33; 95% confidence interval, 0.16 to 0.70; P=0.002). As compared with men who received placebo, men who received zoledronic acid had fewer moderate-to-severe vertebral fractures (P=0.03) and less height loss (P=0.002). Fewer participants who received zoledronic acid had clinical vertebral or nonvertebral fractures, although this difference did not reach significance because of the small number of fractures. Bone mineral density was higher and bone-turnover markers were lower in the men who received zoledronic acid (P<0.05 for both comparisons). Results were similar in men with low serum levels of total testosterone. The zoledronic acid and placebo groups did not differ significantly with respect to the incidence of death (2.6% and 2.9%, respectively) or serious adverse events (25.3% and 25.2%). CONCLUSIONS: Zoledronic acid treatment was associated with a significantly reduced risk of vertebral fracture among men with osteoporosis. (Funded by Novartis Pharma; ClinicalTrials.gov number, NCT00439647.).
Resumo:
Catalunya és un país energèticament dependent d'altres països. A part d'això, la seva producció i el seu consum d'energia provenen de fonts no renovables. Catalunya queda molt lluny de la majoria de països europeus els quals tenen un desenvolupament molt avançat en quan l'explotació de les energies renovables. Segons estudis de l'IDAE i l'ICAEN a les llars espanyoles i catalanes, al voltant d'un 25% del consum d'energia és per part d'electrodomèstics i d'il·luminació. El present treball estima el consum energètic dels pisos a la Vila Universitària 1 i fer una proposta de reducció de consum per mitjà d'un canvi d'electrodomèstics. Aquesta proposta ha estat efectiva ja que el consum estimat es redueix un 50% aproximadament canviant alguns dels electrodomèstics que hi ha actualment per altres de més eficients. Alhora, s'ha dut a terme un concurs d'estalvi energètic juntament amb una campanya de sensibilització de la mateixa temàtica que també busca la disminució del consum energètic en els pisos i, resulta ser quelcom efectiu donat que hi ha hagut una reducció d'un 32% aproximadament en mitjana del consum energètic als pisos. Sembla ser molt important la conscienciació de la gent ja que permet reduir el consum energètic amb un cost econòmic zero.